Corcept Therapeutics
CORT
#1751
Rank
NZ$21.05 B
Marketcap
NZ$194.80
Share price
-3.24%
Change (1 day)
67.09%
Change (1 year)

EPS for Corcept Therapeutics (CORT)

EPS in 2026 (TTM): NZ$0.75

According to Corcept Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ$0.77. In 2025 the company made an earnings per share (EPS) of NZ$1.60 a decrease over its 2024 EPS that were of NZ$2.30.

EPS history for Corcept Therapeutics from 2017 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$0.75-53.39%
2025NZ$1.60-30.37%
2024NZ$2.30
2022NZ$1.62-2.06%
2021NZ$1.655.43%
2020NZ$1.5710.84%
2019NZ$1.4127.69%
2018NZ$1.11-42.48%
2017NZ$1.92

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$14.86 1,841.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$11.94 1,460.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.23 191.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$48.03 6,172.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.08 694.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$6.06 691.11%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
NZ-$0.12-115.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ-$0.03403-104.44%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$2.38 211.11%๐Ÿ‡บ๐Ÿ‡ธ USA